Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 958, pseudogene (RNU6-958P) is a pseudogene of the U6 small nuclear RNA (snRNA) family in Homo sapiens. U6 snRNA genes encode components of the spliceosome required for RNA splicing, but pseudogenes like RNU6-958P are non-functional genomic copies that do not encode a functional RNA product. They arise via retrotransposition and serve as genomic markers of retrotransposition activity, such as LINE-1 (L1) activity, but do not have known biological or therapeutic functions. There is no clinical or disease relevance, and it is not considered a therapeutic target or biomarker. This gene is referenced by authoritative sources including NCBI, HUGO Gene Nomenclature Committee (HGNC), GeneCards, and Monarch Initiative, all classifying it as a pseudogene. U6 snRNA pseudogenes are remnants of the functional U6 gene, created by retrotransposition. They do not encode active snRNAs and are considered non-protein-coding sequences. There is no evidence that RNU6-958P produces a functional product or is involved in any disease or biological process; functional studies on related mouse pseudogenes also report no molecular or process annotation. No drugs, mechanisms of action, or safety issues are associated with this pseudogene. The role of U6 snRNA functional genes is in pre-mRNA splicing, but pseudogenes are non-functional and do not participate in these biological processes.
Not applicable—pseudogene, not a drug target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 958, pseudogene (RNU6-958P).